-
TOPCON selected for the fourth consecutive year as a Digital Transformation Stock (DX stock), and first time chosen for the DX Grand Prix!
Topcon Corporation (Headquarters: Itabashi, Tokyo; President and CEO: Takashi Eto) has been selected for the DX Grand Prix 2023 in the Digital Transformation Stock (DX Stock) designated by the METI (Ministry of Economy, Trade, and Industry) and the Tokyo Stock Exchange.DX Stocks are selected for each industry category, targeting companies listed on the Tokyo Stock Exchange that have established internal systems to promote DX that contributes to improving corporate value. These companies fundamentally transform their business models based on digital technologies and aim to achieve new growth and enhance their competitiveness through digital transformation.Topcon has been selected for four consecutive years since 2020, and this year was chosen as a “DX Grand Prix company,” an award for being a leading company in the selected stocks.Topcon’s corporate identity is “Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” We have been creating new markets by providing DX solutions that transform conventional work processes through digitization, automation, and networking technologies in the global healthcare, agriculture, and infrastructure markets.■ Topcon’s DX Solutions for Solving Societal Challenges in Healthcare, Agriculture, and Infrastructure.[DX Grand Prix 2023 Evaluation Points]Topcon places DX as a driving force for business transformation, and the evaluation points are comprehensive and specific in terms of contributing to corporate value and realization capabilities. The corporate identity states that ” Topcon contributes to enrich human life by solving the societal challenges within healthcare, agriculture, and infrastructure.” and aims to solve these issues with DX solutions. The company actively engages in M&A and partnerships, incorporating advanced technologies and expanding services. They provide integrated solutions that combine technology and services, not just selling products or services, to address the challenges in the target industries. Expectations are high for future developments.Going forward, with a customer-oriented, field-oriented approach and a spirit of challenge, we will continue to strive for “the company that is needed” by stakeholders and promote ESG (environmental, social, and governance) management through our business
-
Topcon Announces eyeRISE 2021 Virtual Symposia & Expo
Two-Day Special Event Will Showcase The Latest Innovations in Eye CareOAKLAND, NJ – January, 2021 – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will host a two-day virtual symposia and expo entitled eyeRISE on February 9-10, 2021.eyeRISE, or Eye Research Innovation Symposia & Expo, is a new, multi-disciplinary virtual congress showcasing the latest innovations in eye care. It will feature three solutions-focused tracks, delivering clinical and practical education through symposia, roundtable discussions and interactive workshops.The two-day special event will feature more than three dozen globally-renowned speakers representing 17 countries and a range of specialties. Educational tracks are Building Clinical Confidence which includes topics focused on retina, glaucoma and imaging; Entering New Markets which addresses the barriers to entering myopia and dry eye management; and Too Many Patients, Not Enough Time highlighting topics such as ocular telehealth and remote diagnostics.“eyeRISE will build on the success of our previous ISSOCT conferences and expand to include all facets of eye care, delivering clinical education for the retina, glaucoma and anterior segment subspecialties. The esteemed lecture panel will present their clinical findings on the latest research topics and innovation in eye care. It should prove to be a highly informative and enlightening meeting for all attendees,”Richard F. Spaide, MD, of Vitreous Retina Macula Consultants of New York, United StatesISSOCT Chairman“We are very excited to announce eyeRISE, a one-of-a-kind, ground-breaking event that will bring together some of the most recognized names in the eye care industry to discuss the latest research and trends in patient care and practice management. In the absence of live meetings, eyeRISE provides an engaging, interactive virtual platform and offers education for a wide range of disciplines. It features solution-focused tracks for real world clinical and business management applications. eyeRISE is the culmination of Topcon’s unwavering commitment to support continued innovation in eye care,” stated Carolyn Evangelista, Global Director of Medical Affairs for Topcon Healthcare.“Having the opportunity to network with colleagues and learn about the latest trends and technologies in eye care is critical for today’s practitioners, particularly in light of the global pandemic. eyeRISE provides practitioners with a unique opportunity to interact with the faculty and each other and gain practical tips and clinical insights. Given the challenges facing today’s eye care practitioners, eyeRISE represents a wonderful learning opportunity for all clinicians,” summarized faculty member Mingguang He, MD, PhD, Professor at the University of Melbourne, Australia.For more information on eyeRISE or to register for the event, please visit Eyerise2021.com.About Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.
-
Topcon Achieves #1 Market Position in OCT Devices
Leads the OCT Market with Innovative Multimodal TechnologyOAKLAND, NJ – October 5, 2020 – Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has achieved the #1 position in the global OCT market, as reported by Market Scope’s 2020 Ophthalmic Diagnostic Equipment Market Report.Topcon leads the global market in the OCT segment with a 27.9 percent share.Its lineup of instruments includes the versatile Maestro2 Robotic OCT and the Triton Swept Source OCT. Both devices combine fundus and OCT functionality in an easy-to-use platform.“The Maestro2 and the Triton are engineered to help ECP’s answer complex clinical questions quickly, easily, and confidently. By delivering multiple images and data points with one click of a button in a format that is easy to understand and interpret, the Maestro2 and Triton meet the demands of today’s busy practitioners. We are thrilled at the way the market has embraced this technology,” stated Greg Hoffmeyer, Director of OCT Clinical Sales for Topcon Healthcare.The versatile Maestro2 combines fundus and OCT functionality in one device.“We are very pleased to have achieved the #1 market position in OCT devices. Our team has been hard at work leveraging the latest technology to develop versatile OCT devices that enhance practice workflow and provide exceptional clinical utility. The Market Scope recognition is confirmation that our devices are being well received by ECPs and are meeting their clinical needs.”About Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.
-
Topcon Acquires Henson Perimeter Business
“The acquisition of the Henson range of products will provide us with the opportunity to strategically develop this area of the company’s product portfolio. With Topcon’s growing emphasis on screening and early disease detection, the Henson product range perfectly complements our global strategy. I welcome the EET team members to the Topcon Healthcare Family.”John Trefethen, Global VP of Marketing & Product Design for Topcon HealthcareAbout Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever- changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management, safe distancing and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.About Elektron Eye Technology (EET)Elektron Eye Technology (Cambridge, UK) is a subsidiary of Elektron Technology and home to spectrum of world-class fast-moving engineered product (FMEP) brands, including the Henson Perimeters and the Macular Pigment Screener (MPS II). They are the ophthalmic instruments of choice for eye care professionals involved in the screening and monitoring of glaucoma and age-related macular degeneration (AMD). Designed in partnership with respected eye care professionals, their accuracy, efficiency and ease of use ensures that they meet the needs of optometrists and ophthalmologists, as well as the patients they work with every day.
-
Topcon Announces the European Launch of MYAH
Company Introduces Comprehensive Management Tool for Myopia and Dry EyeCAPELLE A/D IJSSEL, Netherlands-- Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it has launched its new MYAH instrument to the European region. MYAH is a comprehensive management tool for eyecare professionals interested in building, managing and growing myopia and dry eye services within their practice or research institution.The versatile, all-in-one MYAH provides all the critical tools needed to support myopia management while also offering an evolving platform to add or grow dry eye management. MYAH incorporates corneal topography including keratoconus screening and pupillometry, axial length measurements by optical low coherence interferometry, progression reports for analyzing treatment efficacy, and a comprehensive suite of dry eye assessment tools. The instrument is compact, easy to operate, and offers rapid capture to ensure patient satisfaction.With the launch of MYAH, Topcon achieves a milestone in the battle against the global myopia epidemic. It is estimated that 50% of the world’s population, including European regions, may be myopic by 20501.For more information on MYAH, please visit www.topconmyah.com.1. Holden, BA, Fricke, TR, Wilson, DA et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016; 123:1036–42. Available from: doi: DOI: 10.1016/j.ophtha.2016.01.006“MYAH is ideally suited to combat the growing crises of both myopia and dry eye disease. Its versatility and ease of use allows eyecare professionals to easily build a myopia service within their practice, educate patients on the implications of myopia and dry eye disease, manage their patients’ conditions, and grow their service offerings.”John Trefethen, Global VP of Marketing & Product DesignAbout Topcon HealthcareTopcon Healthcare sees eye health differently. Our vision is to empower providers with smart and efficient technologies for enhanced patient care. Keeping pace with the ever-changing landscape of the healthcare industry, we offer the latest integrated solutions including advanced multimodal imaging, vendor-neutral data management and ground-breaking remote diagnostic technology.A globally-oriented business, Topcon is focused on developing solutions towards solving societal challenges in the mega-domains of healthcare, agriculture, and infrastructure. In healthcare, these challenges include increasing eye disease, rising medical costs, access to healthcare and physician shortages. By investing in value-driven innovations, Topcon works to enable people to enjoy good health and a high quality of life.
-
Topcon Announces the Release of the New SL-D4 LED Slit Lamp with LED Illumination* to the Export Market
Topcon is pleased to announce the release of the new SL-D4 LED Slit Lamp with LED illumination* to the Export Market. This new instrument continues the creativity and growth that Topcon provides the ophthalmic community with the most advanced technology in ophthalmic equipment.